ArticleBMC infectious diseases2026
Prevalence, resistance profile of ESKAPEE pathogens, and molecular detection of PMQR-associated genes among Levofloxacin-resistant gram-negative ESKAPEE isolates from critically-ill patients.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundESKAPEE pathogens are characterized with rapid emergence of antibiotic resistance.
aimTo detect the prevalence, resistance profile of ESKAPEE pathogens, and to analyze the Plasmid-Mediated Quinolone Resistance (PMQR)-associated genes among Levofloxacin-resistant gram-negative ESKAPEE pathogens isolated from critically ill patients in Fayoum University Hospitals, Egypt.
methodsA cross-sectional study was conducted from August 2021 to July 2022. Different specimens were collected and cultured on bacteriological media according to their respective sample sources. The identification of ESKAPEE isolates was performed according to standard microbiological methods. Antimicrobial susceptibilities were determined using Kirby-Baur disk diffusion method. The minimum inhibitory concentration (MIC) of levofloxacin was determined by microdilution method. Molecular identification of PMQR genes in Gram negative ESKAPEE isolates was performed by PCR.
resultsEighty-one samples were collected from 72 patients enrolled in the study. Eighty-four isolates were recovered, from them ESKAPEE pathogens represent 79/84 (94%) of all isolates. Enterococcus faecium was the predominant organism (21.4%). 77.8% of E. faecium were vancomycin-resistant Enterococcus (VRE). Also, 80% of P. aeruginosa, 83.3% of E. coli and 71.4% of K. pneumoniae isolates were extensively drug resistant (XDR). qnrB [78.9% (30/38)] was the most frequently detected gene among ESKAPEE pathogens. Most tested isolates (86.8%) have more than one PMQR gene.
conclusionsA high prevalence of ESKAPEE organisms was detected in ICU infected patients. qnrB was the most frequently PMQR detected genes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.